SCHEMBL9640397

SCHEMBL9640397

Cc1cccc(C)c1NC(=O)NCC1(c2ccccc2)CCCC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.65
LMNA P02545 4/20 0.58
SMN1; SMN2 Q16637 4/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
SOAT2 O75908 1/20 0.55
ACAT1 P24752 1/20 0.55
SOAT1 P35610 1/20 0.55
MAPT P10636 1/20 0.55
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
HSD17B10 Q99714 1/20 0.53
CNR1 P21554 1/20 0.53
ALDH1A1 P00352 3/20 0.52
POLB P06746 1/20 0.52
MAPK1 P28482 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C19 P33261 1/20 0.52
GAA P10253 1/20 0.52
P2RX7 Q99572 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9641050 0.99 TP53 (0.64) TP53LMNASMN1; SMN2L3MBTL1NPSR1
SCHEMBL9641162 0.89 TP53 (0.57) TP53LMNASMN1; SMN2L3MBTL1NPSR1
SCHEMBL9640319 0.89 SOAT1 (0.68) TP53LMNASMN1; SMN2L3MBTL1NPSR1
SCHEMBL9640371 0.88 SOAT1 (0.67) TP53LMNASMN1; SMN2L3MBTL1NPSR1
SCHEMBL9640344 0.88 TP53 (0.56) TP53LMNASMN1; SMN2L3MBTL1NPSR1
SCHEMBL9641110 0.85 LMNA (0.57) TP53LMNASMN1; SMN2L3MBTL1NPSR1
SCHEMBL9818610 0.85 TP53 (0.79) TP53LMNASMN1; SMN2L3MBTL1NPSR1
SCHEMBL9640346 0.84 LMNA (0.56) TP53LMNASMN1; SMN2L3MBTL1NPSR1
SCHEMBL9200734 0.83 SOAT1 (0.77) TP53LMNASMN1; SMN2L3MBTL1NPSR1
SCHEMBL9641246 0.82 SOAT1 (0.76) TP53LMNASMN1; SMN2L3MBTL1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0293880-B1 ANTIHYPERLIPIDEMIC AND ANTIATHEROSCLEROTIC UREA COMPOUNDS WARNER-LAMBERT COMPANY (US) 1992-08-26 EP claimed
EP-0293880-B1 ANTIHYPERLIPIDEMIC AND ANTIATHEROSCLEROTIC UREA COMPOUNDS WARNER-LAMBERT COMPANY (US) 1992-08-26 EP disclosed
US-5015644-A Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds WARNER-LAMBERT COMPANY (US) 1991-05-14 US disclosed
EP-0293880-A1 Antihyperlipidemic and antiatherosclerotic urea compounds WARNER-LAMBERT COMPANY (US) 1988-12-07 EP disclosed